Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

Recruiting now

Conditions studied: Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication

In brief

This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.

Key facts

Study ID

NCT05907681

Run by

Samsung Medical Center

People needed

400

Starts

2023-05-11

Expected to finish

2033-12-31

Last updated by the study team

2025-06-29

Who can join

Age: 19 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• histologically confirmed breast cancer
• presence of distant metastasis
• radiation therapy using IMRT, SBRT, or proton therapy is done or planned
• Able and willing to comply with the study protocol

You may not qualify if…

• unable to adhere to the study protocol

Where it is running

• Samsung Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.